Thrombotic thrombocytopenia After Sinopharm BBIBP-CorV COVID-19 vaccination
Background: Severe side effects after vaccination with coronavirus disease 2019 (COVID-19) vaccines are rare but can be fatal. To date, vaccine-induced immune thrombotic thrombocytopenia (VITT) cases have been reported after injection of mRNA and adenoviral vectors COVID-19 vaccines. Here, we report...
Main Authors: | Barary, M. (Author), Hosseinzadeh, R. (Author), Khosravi, S. (Author), Langer, F. (Author), Mehdinezhad, H. (Author), Sio, T.T (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
John Wiley and Sons Inc
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter]
by: Shuja SH, et al.
Published: (2021-09-01) -
Side effects and perceptions following Sinopharm COVID-19 vaccination
by: Balsam Qubais Saeed, et al.
Published: (2021-10-01) -
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
by: Michael Makris, et al.
Published: (2021-07-01) -
Qualitative Assessment of Early Adverse Effects of Pfizer–BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews
by: Sami Abu-Halaweh, et al.
Published: (2021-08-01) -
Using the Bradford-Hill criteria to assess causality in the association between CHADOX1 NCOV-19 vaccine and thrombotic immune thrombocytopenia
by: C Raina MacIntyre
Published: (2021-04-01)